Danaher shares jump 7% as the turnaround in biotech spending finally arrives

Earnings

In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 
Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Shares of Danaher popped more than 7% on Tuesday after the life sciences company delivered beats across its three main businesses — a sign the long-awaited turnaround in the biotech industry is finally here.

Articles You May Like

Top Stock Picks for Week of July 14, 2025
Why Free Cash Flow Drives Superior Returns
Hims & Hers Health (HIMS) and DXC Technology (DXC): 7/14/25 Bull & Bear
The Week In AI: Cheap House Robots and Pricey Manhattan Projects